Table of contents

  1. Front Matter
    Pages i-xi
  2. Robert K. Oldham
    Pages 1-16
  3. Sun-Jin Kim, Cheryl Hunt Baker, Yasuhiko Kitadai, Toru Nakamura, Toshio Kuwai, Takamitsu Sasaki et al.
    Pages 17-40
  4. Kapil Mehta, Bulent Ozpolat, Kishorchandra Gohil, Bharat B. Aggarwal
    Pages 53-83
  5. Robert K. Oldham
    Pages 85-99
  6. Kenneth A. Foon, Malek M. Safa
    Pages 147-153
  7. Walter M. Lewko, Robert K. Oldham
    Pages 155-276
  8. David Goldstein, Robert Jones, Richard V. Smalley, Ernest C. Borden
    Pages 277-301
  9. Robert O. Dillman
    Pages 303-406
  10. Arthur E. Frankel, Jung-Hee Woo, David M. Neville
    Pages 407-449
  11. Malek Safa, Kenneth A. Foon, Robert K. Oldham
    Pages 451-462
  12. John M. Pagel, Otto C. Boerman, Hazel B. Breitz, Ruby F. Meredith
    Pages 463-496
  13. Kapil Mehta, Robert K. Oldham, Bulent Ozpolat
    Pages 527-568
  14. MaryAnn Foote, George Morstyn
    Pages 569-580
  15. Maryann Foote, George Morstyn
    Pages 581-588
  16. Donald J. Buchsbaum, C. Ryan Miller, Lacey R. Mcnally, Sergey A. Kaliberov
    Pages 589-612

About this book

Introduction

At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. By 2003 and the fourth edition, it was generally agreed that biopharmaceuticals were producing major opportunities for new cancer therapies. Cancer biotherapy has now truly matured into the fourth modality of cancer treatment. This fifth revised edition describes the tremendous progress that has been made in recent years using biologicals in cancer treatment.

This book summarizes an evolving science and a rapidly changing medical practice in biotherapy. In this new millennium, it is now possible to envision a much more diversified system of cancer research and treatment that will afford greater opportunities for a patient’s personalized cancer treatment. This was first envisioned in the 1987 initial edition of this textbook and is now a "new" and popular approach to cancer treatment. Some forms of cancer biotherapy use the strategy of tumor stabilization and control though continued biological therapy, akin to the use of insulin in the treatment of diabetes.

This textbook illustrates new methods of thinking and new strategies for control of cancer. It is always difficult to move from past dogma to future opportunity, but this fifth edition of Principles of Cancer Biotherapy illustrates why it is so important to the patients for researchers and clinicians to explore and quickly apply these new opportunities in cancer biotherapy.

Keywords

Tumor gene therapy interferon therapy transplantation

Editors and affiliations

  • Robert K. Oldham
    • 1
  • Robert O. Dillman
    • 2
    • 3
  1. 1.Hematology-Oncology Associates of Southeast Missouri Hospital, Southeast Medical PlazaCape GirardeauUSA
  2. 2.Hoag Cancer CenterNewport BeachUSA
  3. 3.University of CaliforniaIrvineUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-90-481-2289-9
  • Copyright Information Springer Science+Business Media B.V. 2009
  • Publisher Name Springer, Dordrecht
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-90-481-2277-6
  • Online ISBN 978-90-481-2289-9
  • About this book